dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Dopazo Taboada, Cristina |
dc.contributor.author | Bilbao Aguirre, Itxarone Izaskun |
dc.contributor.author | García García, Sonia |
dc.contributor.author | Gomez Gavara, Concepción |
dc.contributor.author | Caralt Barba, Mireia |
dc.contributor.author | Campos Varela, Isabel |
dc.contributor.author | Castells Fusté, Lluis |
dc.contributor.author | Moreso Mateos, Francesc |
dc.contributor.author | Montoro Ronsano, J. Bruno |
dc.contributor.author | Charco Torra, Ramon |
dc.contributor.author | Hidalgo Llompart, Ernest |
dc.date.accessioned | 2022-08-18T09:13:31Z |
dc.date.available | 2022-08-18T09:13:31Z |
dc.date.issued | 2022-06 |
dc.identifier.citation | Dopazo C, Bilbao I, García S, Gómez-Gavara C, Caralt M, Campos-Varela I, et al. High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation. Clin Transl Sci. 2022 Jun;15(6):1544–55. |
dc.identifier.issn | 1752-8062 |
dc.identifier.uri | https://hdl.handle.net/11351/8014 |
dc.description | Trasplantament hepàtic; Tacrolimús; Malalties del fetge |
dc.description.sponsorship | Isabel Campos-Varela’s research activity is funded by grant PI19/00330 from Instituto de Salud Carlos III. CIBERehd is supported by Instituto de Salud Carlos III. The work was independent of all funding. |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Clinical and Translational Science;15(6) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Fetge - Trasplantació - Complicacions |
dc.subject | Antibiòtics macròlids - Efectes secundaris |
dc.subject.mesh | Liver Transplantation |
dc.subject.mesh | Tacrolimus |
dc.subject.mesh | /adverse effects |
dc.title | High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1111/cts.13276 |
dc.subject.decs | trasplante de hígado |
dc.subject.decs | tacrolimus |
dc.subject.decs | /efectos adversos |
dc.relation.publishversion | https://doi.org/10.1111/cts.13276 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Dopazo C, Bilbao I, Gómez-Gavara C, Caralt M, Hidalgo E, Charco R] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [García S, Montoro B] Servei de Farmàcia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Campos-Varela I, Castells L] Unitat del Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. [Moreso F] Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 35373449 |
dc.identifier.wos | 000783654400001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00330 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |